A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8422-8430

  Wang, Suming ^a,c   Vos, Jean Michel ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c IOWA METHODIST MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE;

ARTICLE; CYTOTOXICITY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HELPER VIRUS; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS HYBRID; VIRUS INFECTION;

EID: 0029959861     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8422-8430.1996     Document Type: Article

References (40)

1. Anderson, W. F. 1992. Human gene therapy. Science 256:808-813.
2. Ausubel, F. M., R. Brent, R. E. Kingston, et al. 1987. Current protocols in molecular biology. John Wiley & Sons, New York.
3. Banerjee, S., L. Livanos, and J.-M. H. Vos. 1995. Therapeutic gene delivery in human β-lymphocytes with non-transforming Epstein-Barr virus. Nat. Med. 1:1303-1308.
4. Coleman, W. B., A. E. Wennerberg, G. J. Smith, and J. W. Grisham. 1993. Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stem-like) cells by the hepatic microenvironment. Am. J. Pathol. 142:1373-1382.
5. Cone, R. D., and R. C. Mulligan. 1984. High-efficiency gene transfer into mammalian cells; generation of helper-free recombinant retrovirus with broad mammalian host range. Proc. Natl. Acad. Sci. USA 81:6349-6353.
6. DeLuca, N. A., and P. A. Schaffer. 1987. Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res. 15:4491-4511.
7. Friedmann, T., and H. A. Jinnah. 1993. Gene therapy for disorders of the nervous system. Trends Biotechnol. 11:192-196.
8. Geller, H. Personal communication.
9. Geller, A. I., and X. O. Breakefleld. 1988. A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 241:1667-1669.
10. Geller, A. I., and A. Freese. 1990. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli β-galactosidase. Proc. Natl. Acad. Sci. USA 87:1149-1153.
11. Geller, A. I., K. Keyonarsi, J. Bryan, and A. B. Pardee. 1990. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc. Natl. Acad. Sci. USA 87:8950-8954.
12. Glorioso, J. Personal communication.
13. Johnson, P. A., A. Miyanohara, F. Levine, T. Cahill, and T. Friedmann. 1992. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol. 66:2952-2965.
14. Jolly, D. 1994. Viral vector systems for gene therapy. Cancer Gene Ther. 1:51-64.
15. Kaplitt, M. G., J. G. Pfaus, S. P. Kleopoulos, B. A. Hanlon, S. D. Rabkin, and D. W. Pfaff. 1991. Expression of a functional foreign gene in adult mammalian brain following in vivo transfer via a herpes simplex virus type 1 defective viral vector. Mol. Cell. Neurosci. 2:320-330.
16. Kioussis, D., F. Wilson, C. Daniels, C. Leveton, J. Taverne, and J. H. L. Playfair. 1987. Expression and rescuing of a cloned human tumor necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J. 6:355-361.
17. Kwong, A. D., and N. Frenkel. 1984. Herpes simplex virus amplicon: effect of size on replication of constructed defective genomes containing eukaryotic DNA sequences. J. Virol. 51:595-603.
18. McGeoch, D. J., M. A. Dalyrymple, A. J. Davison, et al. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:1531-1574.
19. Miller, A. D. 1992. Human gene therapy comes of age. Nature (London) 357:455-460.
20. Miller, A. D., M.-F. Law, and I. M. Verma. 1985. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol. Cell. Biol. 5:431-437.
21. Mulligan, R. C. 1993. The basic science of gene therapy. Science 260:926-932.
22. Paterson, T., and R. D. Everett. 1990. A prominent serine-rich region in Vmw175, the major regulatory protein of herpes simplex virus type 1 is not essential for virus growth in tissue culture. J. Gen. Virol. 71:1775-1783.
23. Rawlins, D. R., G. Milman, S. D. Hayward, and G. S. Hayward. 1985. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42:859-868.
24. Reisman, D., J. L. Yates, and B. Sugden. 1985. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5:1822-1832.
25. Samulski, R. J., L. S. Chang, and T. Shenk. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
26. Spaete, R. R., and N. Frenkel. 1982. The herpes simplex virus amplicon: a new eukaryotic defective virus cloning-amplifying vector. Cell 30:295-304.
27. Spaete, R. R., and N. Frenkel. 1985. The herpes simplex virus amplicon: analyses of cis-acting replication functions. Proc. Natl. Acad. Sci. USA 82: 694-698.
28. Stevens, J. G. 1989. Human herpesviruses: a consideration of the latent state. Microbiol. Rev. 53:318-332.
29. Stow, N. D., and E. C. McMonagle. 1983. Characterization of the TRs/IRs origin of DNA replication of herpes simplex virus type 1. Virology 130:427-438.
30. Stow, N. D., M. D. Murray, and E. C. Stow. 1986. Cis-acting signals involved in the replication and packaging of herpes simplex virus type-1 DNA. Cancer Cells 4:497-507.
31. Sun, T.-Q., D. Fenstermacher, and J.-H. H. Vos. 1994. Human artificial episomal chromosomes for cloning large DNA in human cells. Nat. Genet. 8:33-41.
32. Sun, T.-Q., E. Livanos, and J.-M. H. Vos. Engineering a mini-herpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes. Gene Ther. J.-H. M. Vos (ed.), in press.
33. Sun, T.-Q., and J.-M. H. Vos. 1992. Packaging of 200 kb engineered DNA as infectious Epstein-Barr virus. Int. J. Genome Res. 1:45-57.
34. Vlazny, D. A., and N. Frenkel. 1981. Replication of herpes simplex virus DNA: localization of replication recognition signals within defective virus genomes. Proc. Natl. Acad. Sci. USA 78:742-746.
35. Vos, J.-M. H. 1995. Herpesviruses as genetic vectors, p. 109-140. In Viruses in human gene therapy. Carolina Academic Press and Chapman & Hall, Durham, N.C., and London.
36. Vos, J.-M. H., E. L. Wauthier, and P. C. Hanawalt. 1989. DNA damage stimulates human cell transformation by integrative but not episomal Epstein-Barr virus-derived plasmid. Mol. Carcinog. 2(5):237-244.
37. Wang, S., and J.-M. Vos. Unpublished data.
38. Yates, J. L., and S. M. Camiolo. 1988. Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1. Cancer Cells 6:197-205.
39. Yates, J. L., N. Warren, D. Reisman, and B. A. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806-3810.
40. Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature (London) 313:812-815.